Illumina (ILMN) Competitors $94.20 -3.00 (-3.09%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$94.58 +0.38 (+0.41%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership. Do institutionals and insiders believe in ILMN or A? 89.4% of Illumina shares are owned by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are owned by institutional investors. 0.2% of Illumina shares are owned by insiders. Comparatively, 0.3% of Agilent Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better valuation & earnings, ILMN or A? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.37B3.41-$1.22B-$7.68-12.27Agilent Technologies$6.51B5.93$1.29B$4.4230.62 Does the media favor ILMN or A? In the previous week, Illumina had 7 more articles in the media than Agilent Technologies. MarketBeat recorded 28 mentions for Illumina and 21 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.25 beat Illumina's score of 0.75 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 15 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 14 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ILMN or A? Illumina has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Do analysts recommend ILMN or A? Illumina presently has a consensus price target of $159.45, indicating a potential upside of 69.27%. Agilent Technologies has a consensus price target of $144.38, indicating a potential upside of 6.69%. Given Illumina's stronger consensus rating and higher probable upside, equities research analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 1 Sell rating(s) 8 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 2.62Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community prefer ILMN or A? Illumina received 246 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.05% of users gave Agilent Technologies an outperform vote while only 65.53% of users gave Illumina an outperform vote. CompanyUnderperformOutperformIlluminaOutperform Votes111065.53% Underperform Votes58434.47% Agilent TechnologiesOutperform Votes86471.05% Underperform Votes35228.95% Is ILMN or A more profitable? Agilent Technologies has a net margin of 19.80% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.43% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Illumina-27.95% 13.37% 5.49% Agilent Technologies 19.80%25.43%13.79% SummaryAgilent Technologies beats Illumina on 11 of the 19 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.92B$5.06B$5.78B$8.98BDividend YieldN/A0.45%4.78%3.85%P/E Ratio-12.2729.0326.4618.82Price / Sales3.413.93457.0180.76Price / Cash21.9637.2944.0437.47Price / Book6.292.007.634.64Net Income-$1.22B-$83.57M$3.18B$245.69M7 Day Performance-6.03%-2.41%-1.82%-2.63%1 Month Performance-33.34%-7.72%0.22%-2.37%1 Year Performance-30.94%-22.00%17.49%13.65% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.7685 of 5 stars$94.20-3.1%$159.45+69.3%-30.9%$14.92B$4.37B-12.279,030AAgilent Technologies4.3532 of 5 stars$134.57-1.4%$144.38+7.3%0.0%$38.39B$6.51B30.4517,900Upcoming EarningsDividend AnnouncementNews CoveragePositive NewsMTDMettler-Toledo International3.9224 of 5 stars$1,273.44-1.8%$1,368.00+7.4%+7.7%$26.64B$3.87B31.4217,300Positive NewsWATWaters3.9948 of 5 stars$369.71-2.5%$390.40+5.6%+13.6%$21.95B$2.96B35.287,900TECHBio-Techne4.9274 of 5 stars$65.94-1.2%$86.57+31.3%-9.5%$10.48B$1.16B66.613,100Analyst DowngradeInsider TradeCRLCharles River Laboratories International4.8258 of 5 stars$152.07-0.7%$200.79+32.0%-32.3%$7.78B$4.13B19.0321,800Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews CoverageBIOBio-Rad Laboratories4.7626 of 5 stars$276.55-9.7%$395.20+42.9%-17.5%$7.74B$2.57B-10.128,030High Trading VolumeBRKRBruker4.8541 of 5 stars$50.04-2.2%$70.50+40.9%-38.0%$7.59B$2.96B24.069,707PACBPacific Biosciences of California2.3012 of 5 stars$1.85+25.0%$2.85+54.3%-69.7%$506.64M$200.52M-1.27730Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeHBIOHarvard Bioscience2.2163 of 5 stars$1.35+1.5%N/A-77.7%$58.89M$112.25M-4.09490Gap DownTMOThermo Fisher Scientific4.7358 of 5 stars$532.580.0%$658.00+23.5%-3.7%$203.71B$42.88B32.22122,000Dividend IncreaseAnalyst RevisionPositive News Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ILMN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ILMN Stock Alerts